Brief: SpectraCure New Treatment System Approved In UK For Use In Clinical Trial
19/09/2022 12:04
Sept 19 (Reuters) - SpectraCure AB (publ) SPEC.ST :
* NEW TREATMENT SYSTEM HAS BEEN APPROVED IN THE UK FOR USE IN A CLINICAL TRIAL
* NEW GENERATION TREATMENT SYSTEM APPROVED BY THE MEDICINES AND HEALTHCARE PRODUCTS
REGULATORY
AGENCY (MHRA) FOR USE IN THE ONGOING CLINICAL TRIAL FOR THE TREATMENT OF RELAPSED PROSTATE
CANCER
Source text for Eikon: ID:nWkr2xN9lb
Further company coverage: SPEC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))